"
Team:Penn
From 2012.igem.org
(Difference between revisions)
| Line 28: | Line 28: | ||
<div class="info_description">We have developed light-activated cell lysis using the YF1/FixJ Blue Light sensor and the ClyA protein. | <div class="info_description">We have developed light-activated cell lysis using the YF1/FixJ Blue Light sensor and the ClyA protein. | ||
| + | <br> | ||
<a href="https://2012.igem.org/Team:Penn/DrugDeliveryResults" class="more">Read more</a> | <a href="https://2012.igem.org/Team:Penn/DrugDeliveryResults" class="more">Read more</a> | ||
</div> | </div> | ||
| Line 38: | Line 39: | ||
<div class="info_heading">Display of ANTi-her2 DARPin</div> | <div class="info_heading">Display of ANTi-her2 DARPin</div> | ||
<div class="info_description"> | <div class="info_description"> | ||
| - | Our team is the first to use the INPNC protein to display the DARPin Anti-HER2 binding protein on the surface of bacteria | + | Our team is the first to use the INPNC protein to display the DARPin Anti-HER2 binding protein on the surface of bacteria <br> |
<a href="https://2012.igem.org/Team:Penn/DrugDeliveryResults" class="more">Read more</a> | <a href="https://2012.igem.org/Team:Penn/DrugDeliveryResults" class="more">Read more</a> | ||
</div> | </div> | ||
Revision as of 00:25, 22 October 2012
|
|
|
|
|
|
|
|
